---
title: "603392.SH (603392.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/603392.SH/news.md"
symbol: "603392.SH"
name: "603392.SH"
parent: "https://longbridge.com/en/quote/603392.SH.md"
datetime: "2026-05-21T10:16:51.575Z"
locales:
  - [en](https://longbridge.com/en/quote/603392.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/603392.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/603392.SH/news.md)
---

# 603392.SH (603392.SH) — Related News

### [Vaccine sector stocks have collectively surged, with some funds entering during the low period to "buy the dip."](https://longbridge.com/en/news/285936446.md)
*2026-05-11T11:43:16.000Z*
> On May 11th, the vaccine sector saw a general rise in stock prices, with WALVAX hitting the limit up, and companies such

### [Hantavirus outbreak draws attention! The virus prevention and control sector collectively surged, Wantai Biological rose by 9%, and BGI Genomics increased by over 5%](https://longbridge.com/en/news/285886879.md)
*2026-05-11T05:47:20.000Z*
> A-share market virus prevention concept stocks collectively rose, Wantai Biological increased by 9%, and BGI Genomics ro

### [Two billionaires face their "darkest hour" together](https://longbridge.com/en/news/285493929.md)
*2026-05-07T06:06:35.000Z*
> Two HPV vaccine companies, Wantai Biological and ZHIFEI-BIOL, are facing a severe financial crisis. Wantai Biological's 

### [Wantai Biological: Net loss of 42.9838 million yuan in the first quarter of 2026](https://longbridge.com/en/news/284186439.md)
*2026-04-27T09:30:33.000Z*
> Wantai Biological announced that its revenue for the first quarter of 2026 was 523 million yuan, a year-on-year increase

### [Financial Report Comparison | WALVAX increases profit without increasing revenue, Wantai Biological reports first loss since listing, where to next?](https://longbridge.com/en/news/283870799.md)
*2026-04-23T13:16:14.000Z*
> WALVAX and Wantai Biological both reported a decline in revenue in their 2025 financial statements. WALVAX achieved an o

### [Wantai Biological reports its first loss since going public: HPV vaccine price cut by 90% still fails to sell, why has the former cash cow malfunctioned? | Financial Report Anomaly Insight](https://longbridge.com/en/news/283634520.md)
*2026-04-22T09:23:08.000Z*
> Wantai Biological reported its first loss in the 2025 financial report, with significant declines in revenue and net pro

### [Wantai Biological reported its first loss since going public last year, stating that the nine-valent HPV vaccine has not yet generated significant profit contributions](https://longbridge.com/en/news/283464427.md)
*2026-04-21T08:38:31.000Z*
> Wantai Biological (603392) reported its first loss in the 2025 financial report, with a net profit attributable to the p

### [Declining batch approvals and pressure on enterprises, is the HPV vaccine market cooling down?](https://longbridge.com/en/news/281985164.md)
*2026-04-08T06:19:07.000Z*
> China's HPV vaccine market is undergoing significant adjustments, with the number of batches approved for release in the

### [Stepping down from a market value of 100 billion, Wantai Biological tackles Merck](https://longbridge.com/en/news/280892811.md)
*2026-03-29T02:06:10.000Z*
> Wantai Biological is undergoing a generational leadership adjustment and has launched the domestically produced nine-val